Newstral
Samit Hirawat
- Where To Invest In 2024 - Value Is UndervaluedForbes
- DKaruna Therapeutics soars after $14 billion takeover by Bristol Myersdcourier.com
- Partnership to give people with disabilities access to experimental medicationswestfaironline.com
- A Potential GSK Game Changer And An MRNA Cancer Vaccine: Highlights From The 2022 ASCO ConferenceForbes
- IHere is Why Turning Point Therapeutics Jumped 110%invezz.com
- Doctors blast Biogen Alzheimer’s drug approval as ‘regulatory failure’thenewstribune.com
- Doctors blast Biogen Alzheimer approval as ‘regulatory failure’The Japan Times
- BBristol Myers Squibb Stock Rises After Modest Earnings Beat3 min readbarrons.com
- MMerger uncertainty and impending clinical trials for Bristol-Myers leave investors in limbomarketwatch.com
Frequent names
Newstral's extraction of names of people and organisations from the world's news is completely automated. If you do not want your name to appear here, please contact us. We will be happy to look at your request.